EP Life Sciences L.P. — Form D/A
EP Life Sciences L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2026-05-14. $507.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-05-14
- Form: D/A
- Accession: 0001744892-26-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Amount sold: $507.8M
- Investors: 170
- Security types: equity, fund interests
- SEC file number: 021-315695
Issuer
- Name: EP Life Sciences L.P.
- CIK: 0001744892
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 375 PARK AVENUE, NEW YORK, NY, 10152
- Phone: 212-751-5959
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Joel S. Ehrenkranz | Related Person | New York, NY |
| John B Ehrenkranz | Related Person | New York, NY |
| Sanford B. Ehrenkranz | Related Person | New York, NY |
| Kabir Kapoor | Related Person | NEW YORK, NY |
| Patrick JC Shaw | Related Person | New York, NY |
| Andrew Sommers | Related Person | New York, NY |
| John B Ehrenkranz | Executive Officer | New York, NY |
| Patrick JC Shaw | Executive Officer | New York, NY |
| Kabir JC Kapoor | Executive Officer | NEW YORK, NY |
| Sanford B Ehrenkranz | Executive Officer | New York, NY |
| Joel S Ehrenkranz | Executive Officer | New York, NY |
| Andrew B Sommers | Executive Officer | New York, NY |
| Kurt JC Dudas | Executive Officer | New York, NY |
Other filings by this issuer (8)
More